期刊文献+

免疫分子诊断急性髓系白血病患者PML/RARα融合基因重排的诊断效能评价 被引量:2

Evaluation of the efficacy of immunomolecular diagnosis of PML/RARα fusion gene rearrangement in patients with acute myeloid leukemia
下载PDF
导出
摘要 目的探讨急性髓系白血病免疫分子与PML/RARα融合基因之间的关系及免疫分子对PML/RARα融合基因表达的诊断效能。方法选取荆州市中心医院2016年7月至2019年2月初诊FAB分型为急性髓系白血病的患者120例,荧光定量PCR检测融合基因PML/RARα,流式细胞术检测CD分子表达,根据融合基因PML/RARα是否表达对患者进行分组,分析免疫分型CD分子表达差异及与融合基因PML/RARα表达的关联。结果PML/RARα阳性患者组CD64阳性患者率高达75.0%,CD34、HLA?DR、CD7阳性患者率分别为7.7%、7.7%、0;PML/RARα阴性患者组CD64阳性患者率为28.6%,CD7、CD34、HLA?DR阳性患者率分别为44.4%、77.8%、63.0%,差异均有统计学意义(P<0.05)。PML/RARα阳性患者中CD64阳性细胞率四分位数均高于PML/RARα阴性患者,CD7、CD34、HLA?DR阳性细胞率四分位数均低于PML/RARα阴性患者。两组间CD64、CD34、HLA?DR阳性细胞率差异均具有统计学意义(P<0.05)。CD34、HLA?DR、CD64诊断临界值分别为10.7%、11.1%、14.2%时诊断PML/RARα为阳性的敏感度和特异度较好。结论CD34、HLA?DR和CD64对诊断急性髓系白血病患者PML/RARα融合基因重排有较好的诊断性能。 Objective To investigate the relationship between immune molecules and PML/RARαfusion gene and the diagnostic efficacy of immune molecules in PML/RARαfusion gene expression in patients with acute myeloid leukemia.Methods A total of 120 patients with acute myeloid leukemia(initially diagnosed with FAB)from July 2016 to February 2019 in Jingzhou Central Hospital were selected.The fusion gene PML/RARαwas de?tected by fluorescence quantitative PCR,and the molecular expression of CDs were measured by flow cytometry.The patients were divided into two groups according to PML/RARαexpression.The expression differences of CDs and their association with PML/RARαwere analyzed.Results In PML/RARαpositive group,patient with posi?tive CD64 expression accounted for 75.0%,and those with positive CD34,HLA?DR and CD77.7%,7.7%and 0,respectively.In PML/RARαnegative group,the rate of patients with positive CD64,CD7,CD34,and HLA?DR was 28.6%,44.4%,77.8%,and 63.0%,respectively.Differences of the rates of patient with positive CDs were statistically significant(P<0.05).Among PML/RARαpositive patients,the quartile of CD64 positive cells was higher than that of PML/RARαnegative patients,and the quartile of CD7,CD34 and HLA?DR positive cells were lower than that of PML/RARαnegative patients.There were statistically significant differences in the rates of CD64,CD34 and HLA?DR positive cells between the two groups(P<0.05).The sensitivity and specificity of posi?tive PML/RARαwas better when the diagnostic thresholds of CD34,HLA?DR and CD64 were 10.7%,11.1%and 14.2%,respectively.Conclusion CD34,HLA?DR and CD64 have good performance in the diagnosis of PML/RARαfusion gene rearrangement in patients with acute myeloid leukemia.
作者 邹惠安 李琳芸 唐元艳 陈永玲 梅冰 ZOU Huian;LI Linyun;TANG Yuanyan;CHEN Yongling;MEI Bing(Sec?ond Clinical Medical College of Yangtze University,Jingzhou 434020,China)
出处 《实用医学杂志》 CAS 北大核心 2019年第21期3374-3377,3383,共5页 The Journal of Practical Medicine
基金 湖北省卫生健康委科研项目(编号:WJ2019F125)
关键词 急性髓系白血病 PML/RARΑ 融合基因 免疫分子 acute myeloid leukemia PML/RARα fusion gene immune molecule
  • 相关文献

参考文献11

二级参考文献90

  • 1时昊,张志瑢,肖爱琴,朱锋,张日.c-kit受体与其他髓系膜抗原标志物对急性非淋巴细胞白血病诊断价值的比较[J].中华内科杂志,2005,44(5):384-385. 被引量:12
  • 2孙秀丽,方美云,姜凤,荆源.免疫分型用于68例急性白血病的分型[J].中国实验血液学杂志,2006,14(1):39-41. 被引量:8
  • 3潘湘涛,李建勇,夏学鸣,薛永权.MIC分型评价成人急-性髓系白血病中的淋系抗原表达[J].肿瘤,2006,26(10):944-946. 被引量:12
  • 4张建军,杜欣,黄志新,苏健华,周茂华.AML-1/ETO基因相关的AML-M_2型白血病免疫表型分析[J].中国实验血液学杂志,2007,15(2):378-381. 被引量:9
  • 5Jordan CT, Guzman NIL, Noble M. Cancer stem ceils. N Engl J Med, 2006;355 (12) : 1253 - 1261.
  • 6AiUes LE, Gerhard B, Kawagoe H, et al. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood, 1999; 94(5): 1761-1772.
  • 7Wojiski S, Guibal FC, Kindler T, et al. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors. Leukemia, 2009; 23 ( 8 ) : 1462 - 1471.
  • 8Guibal FC, Alberich-Jorda M, Hirai H, et al. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood, 2009 ; 114 (27) : 5415 - 5425.
  • 9Viale A, De Franco F, Orleth A, et al. Cell-cycle restriction limits DNA damage and maintain self-renewal of leukaemia stem ceils. Nature, 2009 ; 457 (7225) :51 - 56.
  • 10Welch JS, Yuan W, Ley TJ. PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice. J Clin Invest, 2011 ; 121(4) :1636 -1645.

共引文献46

同被引文献12

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部